 Steven Thorpe
Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoma | 20 | 2024 | 176 | 5.520 |
Why?
| | Soft Tissue Neoplasms | 11 | 2024 | 112 | 3.880 |
Why?
| | Bone Neoplasms | 14 | 2025 | 231 | 2.680 |
Why?
| | Margins of Excision | 3 | 2024 | 38 | 1.880 |
Why?
| | Intraoperative Care | 2 | 2024 | 46 | 1.150 |
Why?
| | Osteosarcoma | 5 | 2025 | 72 | 0.980 |
Why?
| | Frozen Sections | 1 | 2024 | 26 | 0.930 |
Why?
| | Surgical Oncology | 1 | 2024 | 22 | 0.920 |
Why?
| | Extremities | 7 | 2023 | 127 | 0.560 |
Why?
| | Sarcoma, Ewing | 3 | 2025 | 89 | 0.560 |
Why?
| | Practice Patterns, Physicians' | 1 | 2024 | 1266 | 0.500 |
Why?
| | Tomography, X-Ray Computed | 3 | 2024 | 2535 | 0.480 |
Why?
| | Subtalar Joint | 1 | 2012 | 3 | 0.390 |
Why?
| | Flatfoot | 1 | 2012 | 12 | 0.390 |
Why?
| | Sarcoma, Synovial | 2 | 2023 | 17 | 0.380 |
Why?
| | Medical Oncology | 2 | 2025 | 272 | 0.380 |
Why?
| | Subclavian Artery | 1 | 2011 | 27 | 0.360 |
Why?
| | Deltoid Muscle | 1 | 2010 | 6 | 0.350 |
Why?
| | Cellulitis | 1 | 2011 | 48 | 0.350 |
Why?
| | Compartment Syndromes | 1 | 2010 | 22 | 0.350 |
Why?
| | Thoracic Vertebrae | 1 | 2011 | 74 | 0.350 |
Why?
| | Prognosis | 13 | 2024 | 3794 | 0.340 |
Why?
| | Joint Instability | 1 | 2012 | 167 | 0.330 |
Why?
| | Deglutition Disorders | 1 | 2011 | 133 | 0.310 |
Why?
| | Osteomyelitis | 1 | 2011 | 122 | 0.310 |
Why?
| | Health Status Disparities | 2 | 2021 | 254 | 0.310 |
Why?
| | Humans | 44 | 2025 | 129621 | 0.300 |
Why?
| | SEER Program | 4 | 2021 | 206 | 0.290 |
Why?
| | Retrospective Studies | 14 | 2024 | 14519 | 0.280 |
Why?
| | Neoplasms | 4 | 2022 | 2470 | 0.270 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2021 | 964 | 0.260 |
Why?
| | Socioeconomic Factors | 4 | 2023 | 1214 | 0.250 |
Why?
| | Social Class | 3 | 2023 | 257 | 0.250 |
Why?
| | Follow-Up Studies | 9 | 2024 | 4896 | 0.240 |
Why?
| | Middle Aged | 17 | 2024 | 31150 | 0.230 |
Why?
| | Survival Rate | 7 | 2024 | 1877 | 0.230 |
Why?
| | Synovitis, Pigmented Villonodular | 1 | 2024 | 3 | 0.220 |
Why?
| | Giant Cell Tumor of Tendon Sheath | 1 | 2024 | 4 | 0.220 |
Why?
| | Killer Cells, Natural | 3 | 2023 | 427 | 0.220 |
Why?
| | Cost-Benefit Analysis | 2 | 2024 | 569 | 0.220 |
Why?
| | Subcutaneous Fat | 1 | 2024 | 74 | 0.220 |
Why?
| | Thorax | 1 | 2023 | 42 | 0.210 |
Why?
| | Intra-Abdominal Fat | 1 | 2024 | 88 | 0.210 |
Why?
| | Young Adult | 9 | 2024 | 12426 | 0.210 |
Why?
| | Femoral Neoplasms | 1 | 2022 | 10 | 0.200 |
Why?
| | Musculoskeletal Diseases | 1 | 2023 | 69 | 0.200 |
Why?
| | Neoplasm Staging | 2 | 2023 | 1295 | 0.200 |
Why?
| | Bone Diseases | 1 | 2022 | 57 | 0.190 |
Why?
| | Aged, 80 and over | 6 | 2024 | 7084 | 0.190 |
Why?
| | Osteoarthritis | 1 | 2024 | 167 | 0.190 |
Why?
| | Foot Diseases | 1 | 2021 | 16 | 0.190 |
Why?
| | Arthrodesis | 2 | 2012 | 31 | 0.180 |
Why?
| | Neoadjuvant Therapy | 3 | 2021 | 383 | 0.180 |
Why?
| | Adult | 14 | 2024 | 35572 | 0.180 |
Why?
| | Radiation Oncology | 1 | 2021 | 75 | 0.180 |
Why?
| | Radiotherapy, Adjuvant | 4 | 2023 | 210 | 0.170 |
Why?
| | Societies, Medical | 1 | 2024 | 751 | 0.170 |
Why?
| | Reoperation | 2 | 2022 | 545 | 0.170 |
Why?
| | Interleukin-15 | 1 | 2020 | 82 | 0.170 |
Why?
| | Body Composition | 1 | 2024 | 649 | 0.170 |
Why?
| | Aged | 11 | 2024 | 22099 | 0.170 |
Why?
| | Male | 19 | 2024 | 63674 | 0.170 |
Why?
| | Insurance, Health | 1 | 2022 | 267 | 0.170 |
Why?
| | Hand | 1 | 2021 | 155 | 0.170 |
Why?
| | Health Equity | 1 | 2021 | 82 | 0.170 |
Why?
| | Spine | 1 | 2021 | 158 | 0.160 |
Why?
| | Hematologic Neoplasms | 1 | 2021 | 140 | 0.160 |
Why?
| | Arteries | 1 | 2021 | 265 | 0.160 |
Why?
| | Female | 19 | 2024 | 68770 | 0.160 |
Why?
| | Combined Modality Therapy | 2 | 2025 | 1206 | 0.160 |
Why?
| | Thoracic Wall | 1 | 2019 | 18 | 0.160 |
Why?
| | Thoracic Neoplasms | 1 | 2019 | 35 | 0.160 |
Why?
| | Healthcare Disparities | 2 | 2023 | 578 | 0.160 |
Why?
| | Radiography | 2 | 2012 | 798 | 0.160 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 211 | 0.150 |
Why?
| | Vascular Surgical Procedures | 1 | 2021 | 294 | 0.150 |
Why?
| | Postoperative Complications | 3 | 2019 | 2483 | 0.150 |
Why?
| | Lower Extremity | 1 | 2022 | 404 | 0.150 |
Why?
| | Hemipelvectomy | 1 | 2018 | 2 | 0.150 |
Why?
| | Chondrosarcoma | 1 | 2018 | 15 | 0.150 |
Why?
| | Adolescent | 10 | 2024 | 20391 | 0.140 |
Why?
| | Osteotomy | 2 | 2022 | 99 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 857 | 0.140 |
Why?
| | Radiotherapy | 1 | 2018 | 188 | 0.140 |
Why?
| | Free Tissue Flaps | 1 | 2018 | 54 | 0.140 |
Why?
| | Child | 10 | 2024 | 20882 | 0.130 |
Why?
| | Preoperative Care | 1 | 2019 | 340 | 0.130 |
Why?
| | Transcription Factors | 1 | 2024 | 1651 | 0.130 |
Why?
| | Databases, Factual | 2 | 2021 | 1269 | 0.130 |
Why?
| | Lymphocytes | 1 | 2018 | 377 | 0.130 |
Why?
| | Health Care Costs | 1 | 2019 | 367 | 0.130 |
Why?
| | Body Mass Index | 1 | 2024 | 2273 | 0.120 |
Why?
| | C-Reactive Protein | 1 | 2018 | 401 | 0.120 |
Why?
| | Incidence | 4 | 2021 | 2644 | 0.120 |
Why?
| | Tumor Microenvironment | 3 | 2023 | 634 | 0.110 |
Why?
| | United States | 8 | 2022 | 13900 | 0.110 |
Why?
| | Age Factors | 3 | 2021 | 3144 | 0.110 |
Why?
| | Infant, Newborn | 5 | 2024 | 5762 | 0.110 |
Why?
| | Treatment Outcome | 6 | 2022 | 10226 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 1717 | 0.100 |
Why?
| | Tarsal Bones | 1 | 2012 | 13 | 0.100 |
Why?
| | Neutrophils | 1 | 2018 | 1205 | 0.100 |
Why?
| | Surveys and Questionnaires | 1 | 2024 | 5401 | 0.100 |
Why?
| | Torso | 2 | 2023 | 31 | 0.100 |
Why?
| | California | 2 | 2024 | 401 | 0.090 |
Why?
| | Infant | 5 | 2024 | 9025 | 0.090 |
Why?
| | Osseointegration | 1 | 2011 | 56 | 0.090 |
Why?
| | Debridement | 1 | 2011 | 83 | 0.090 |
Why?
| | Immobilization | 1 | 2010 | 45 | 0.090 |
Why?
| | Child, Preschool | 5 | 2024 | 10518 | 0.090 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1614 | 0.090 |
Why?
| | Fatal Outcome | 1 | 2011 | 300 | 0.080 |
Why?
| | Necrosis | 1 | 2010 | 232 | 0.080 |
Why?
| | Cervical Vertebrae | 1 | 2011 | 133 | 0.080 |
Why?
| | Pain Measurement | 1 | 2012 | 506 | 0.080 |
Why?
| | Orthopedic Procedures | 1 | 2012 | 210 | 0.080 |
Why?
| | Prospective Studies | 4 | 2024 | 7131 | 0.080 |
Why?
| | Proportional Hazards Models | 2 | 2023 | 1201 | 0.080 |
Why?
| | Recovery of Function | 1 | 2012 | 642 | 0.070 |
Why?
| | Spinal Fusion | 1 | 2011 | 230 | 0.070 |
Why?
| | Risk Assessment | 2 | 2018 | 3240 | 0.070 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2012 | 626 | 0.070 |
Why?
| | Head and Neck Neoplasms | 1 | 2012 | 544 | 0.070 |
Why?
| | Cohort Studies | 3 | 2021 | 5420 | 0.060 |
Why?
| | Sex Factors | 2 | 2021 | 1968 | 0.060 |
Why?
| | Disease-Free Survival | 2 | 2020 | 648 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 2 | 2019 | 3408 | 0.060 |
Why?
| | Pain | 1 | 2011 | 789 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2742 | 0.050 |
Why?
| | Watchful Waiting | 1 | 2024 | 67 | 0.050 |
Why?
| | Smoking | 1 | 2011 | 1501 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1565 | 0.050 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 259 | 0.050 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2023 | 171 | 0.050 |
Why?
| | Antibiotic Prophylaxis | 1 | 2023 | 101 | 0.050 |
Why?
| | Bone Marrow | 1 | 2023 | 271 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2024 | 399 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2024 | 814 | 0.050 |
Why?
| | Prosthesis Failure | 1 | 2022 | 114 | 0.050 |
Why?
| | Vascular Grafting | 1 | 2021 | 13 | 0.050 |
Why?
| | Genetic Testing | 1 | 2024 | 428 | 0.050 |
Why?
| | Sacrum | 1 | 2022 | 74 | 0.050 |
Why?
| | Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2021 | 2 | 0.050 |
Why?
| | Vascular Patency | 1 | 2021 | 102 | 0.050 |
Why?
| | Prosthesis Implantation | 1 | 2022 | 145 | 0.050 |
Why?
| | Insurance Coverage | 1 | 2022 | 219 | 0.040 |
Why?
| | Prosthesis Design | 1 | 2022 | 306 | 0.040 |
Why?
| | Femur | 1 | 2022 | 244 | 0.040 |
Why?
| | Bone and Bones | 1 | 2023 | 299 | 0.040 |
Why?
| | Surgical Wound Infection | 1 | 2023 | 283 | 0.040 |
Why?
| | Guideline Adherence | 1 | 2024 | 526 | 0.040 |
Why?
| | Dogs | 1 | 2020 | 381 | 0.040 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 370 | 0.040 |
Why?
| | Sarcopenia | 1 | 2020 | 74 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2024 | 1356 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 1 | 2020 | 857 | 0.040 |
Why?
| | Organ Preservation | 1 | 2018 | 94 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2018 | 326 | 0.030 |
Why?
| | Perfusion | 1 | 2018 | 197 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 3215 | 0.030 |
Why?
| | Mice | 2 | 2024 | 16937 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 2020 | 395 | 0.030 |
Why?
| | Inpatients | 1 | 2021 | 467 | 0.030 |
Why?
| | Animals | 3 | 2024 | 35360 | 0.030 |
Why?
| | Tissue Engineering | 1 | 2020 | 396 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2024 | 1501 | 0.030 |
Why?
| | Survival Analysis | 1 | 2019 | 1274 | 0.030 |
Why?
| | Wound Healing | 1 | 2018 | 305 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1097 | 0.030 |
Why?
| | Graft Survival | 1 | 2018 | 512 | 0.030 |
Why?
| | Ischemia | 1 | 2018 | 406 | 0.030 |
Why?
| | Registries | 1 | 2021 | 1895 | 0.030 |
Why?
| | Medicare | 1 | 2019 | 720 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 1952 | 0.020 |
Why?
| | Carboplatin | 1 | 2012 | 140 | 0.020 |
Why?
| | Radiotherapy Dosage | 1 | 2012 | 252 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2070 | 0.020 |
Why?
| | Pseudarthrosis | 1 | 2011 | 11 | 0.020 |
Why?
| | Radiotherapy, Intensity-Modulated | 1 | 2012 | 129 | 0.020 |
Why?
| | Spinal Stenosis | 1 | 2011 | 27 | 0.020 |
Why?
| | Paclitaxel | 1 | 2012 | 217 | 0.020 |
Why?
| | Radiculopathy | 1 | 2011 | 33 | 0.020 |
Why?
| | Chemoradiotherapy | 1 | 2012 | 210 | 0.020 |
Why?
| | Bone Transplantation | 1 | 2011 | 83 | 0.020 |
Why?
| | Quality of Life | 1 | 2021 | 2704 | 0.020 |
Why?
| | Risk Factors | 1 | 2022 | 9763 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 6556 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2012 | 1367 | 0.020 |
Why?
|
|
Thorpe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|